182 related items for PubMed ID: 10603129
1. Prolonged versus standard prednisolone therapy for initial episode of nephrotic syndrome.
Bagga A, Hari P, Srivastava RN.
Pediatr Nephrol; 1999 Nov; 13(9):824-7. PubMed ID: 10603129
[Abstract] [Full Text] [Related]
2. Prolonged versus standard prednisolone therapy for initial episode of idiopathic nephrotic syndrome.
Mishra OP, Thakur N, Mishra RN, Prasad R.
J Nephrol; 2012 Nov; 25(3):394-400. PubMed ID: 21928226
[Abstract] [Full Text] [Related]
3. Extending initial prednisolone treatment in a randomized control trial from 3 to 6 months did not significantly influence the course of illness in children with steroid-sensitive nephrotic syndrome.
Sinha A, Saha A, Kumar M, Sharma S, Afzal K, Mehta A, Kalaivani M, Hari P, Bagga A.
Kidney Int; 2015 Jan; 87(1):217-24. PubMed ID: 25029428
[Abstract] [Full Text] [Related]
4. Long versus standard initial prednisolone therapy in children with idiopathic nephrotic syndrome.
Paul SK, Muinuddin G, Jahan S, Begum A, Rahman MH, Hossain MM.
Mymensingh Med J; 2014 Apr; 23(2):261-7. PubMed ID: 24858152
[Abstract] [Full Text] [Related]
5. Efficacy of low-dose daily versus alternate-day prednisolone in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial.
Yadav M, Sinha A, Khandelwal P, Hari P, Bagga A.
Pediatr Nephrol; 2019 May; 34(5):829-835. PubMed ID: 30194663
[Abstract] [Full Text] [Related]
6. Can we predict relapses in children with idiopathic steroid-sensitive nephrotic syndrome?
Mishra OP, Abhinay A, Mishra RN, Prasad R, Pohl M.
J Trop Pediatr; 2013 Oct; 59(5):343-9. PubMed ID: 23619602
[Abstract] [Full Text] [Related]
7. [Standard versus long-term prednisolone with sairei-to for initial therapy in childhood steroid-responsive nephrotic syndrome: a prospective controlled study].
Yoshikawa N, Ito H, Takekoshi Y, Honda M, Awazu M, Iijima K, Nakamura H, Seino Y, Takeda N, Hattori S, Matsuda I.
Nihon Jinzo Gakkai Shi; 1998 Nov; 40(8):587-90. PubMed ID: 9893457
[Abstract] [Full Text] [Related]
8. Initial treatment of idiopathic nephrotic syndrome in children: prednisone versus prednisone plus cyclosporine A: a prospective, randomized trial.
Hoyer PF, Brodeh J.
J Am Soc Nephrol; 2006 Apr; 17(4):1151-7. PubMed ID: 16540560
[Abstract] [Full Text] [Related]
9. Short courses of daily prednisolone during upper respiratory tract infections reduce relapse frequency in childhood nephrotic syndrome.
Abeyagunawardena AS, Thalgahagoda RS, Dissanayake PV, Abeyagunawardena S, Illangasekera YA, Karunadasa UI, Trompeter RS.
Pediatr Nephrol; 2017 Aug; 32(8):1377-1382. PubMed ID: 28341877
[Abstract] [Full Text] [Related]
10. Increasing the dose of prednisolone during viral infections reduces the risk of relapse in nephrotic syndrome: a randomised controlled trial.
Abeyagunawardena AS, Trompeter RS.
Arch Dis Child; 2008 Mar; 93(3):226-8. PubMed ID: 17573408
[Abstract] [Full Text] [Related]
11. Long term tapering versus standard prednisolone treatment for first episode of childhood nephrotic syndrome: phase III randomised controlled trial and economic evaluation.
Webb NJA, Woolley RL, Lambe T, Frew E, Brettell EA, Barsoum EN, Trompeter RS, Cummins C, Deeks JJ, Wheatley K, Ives NJ, PREDNOS Collaborative Group.
BMJ; 2019 May 23; 365():l1800. PubMed ID: 31335316
[Abstract] [Full Text] [Related]
12. Long versus standard initial steroid therapy for children with the nephrotic syndromeA report from the Southwest Pediatric Nephrology Study Group.
Lande MB, Gullion C, Hogg RJ, Gauthier B, Shah B, Leonard MB, Bonilla-Felix M, Nash M, Roy S, Strife CF, Arbus G.
Pediatr Nephrol; 2003 Apr 23; 18(4):342-6. PubMed ID: 12700959
[Abstract] [Full Text] [Related]
13. [Initial therapy of primary nephrotic syndrome in children: evaluation in a period of 18 months of two prednisone treatment schedules. Chilean Co-operative Group of Study of Nephrotic Syndrome in Children].
Norero C, Delucchi A, Lagos E, Rosati P.
Rev Med Chil; 1996 May 23; 124(5):567-72. PubMed ID: 9035508
[Abstract] [Full Text] [Related]
14. Short versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children. Arbeitsgemeinschaft für Pädiatrische Nephrologie.
Lancet; 1988 Feb 20; 1(8582):380-3. PubMed ID: 2893190
[Abstract] [Full Text] [Related]
15. Short-Duration Prednisolone in Children with Nephrotic Syndrome Relapse: A Noninferiority Randomized Controlled Trial.
Kainth D, Hari P, Sinha A, Pandey S, Bagga A.
Clin J Am Soc Nephrol; 2021 Feb 08; 16(2):225-232. PubMed ID: 33478976
[Abstract] [Full Text] [Related]
16. Prevention of relapses with levamisole as adjuvant therapy in children with a first episode of idiopathic nephrotic syndrome: study protocol for a double blind, randomised placebo-controlled trial (the LEARNS study).
Veltkamp F, Khan DH, Reefman C, Veissi S, van Oers HA, Levtchenko E, Mathôt RAA, Florquin S, van Wijk JAE, Schreuder MF, Haverman L, Bouts AHM.
BMJ Open; 2019 Aug 01; 9(8):e027011. PubMed ID: 31375606
[Abstract] [Full Text] [Related]
17. Long-term, low-dose prednisolone therapy in frequently relapsing nephrotic syndrome.
Srivastava RN, Vasudev AS, Bagga A, Sunderam KR.
Pediatr Nephrol; 1992 May 01; 6(3):247-50. PubMed ID: 1616833
[Abstract] [Full Text] [Related]
18. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
Choudhry S, Bagga A, Hari P, Sharma S, Kalaivani M, Dinda A.
Am J Kidney Dis; 2009 May 01; 53(5):760-9. PubMed ID: 19268410
[Abstract] [Full Text] [Related]
19. Zinc supplement in reduction of relapses in children with steroid sensitive nephrotic syndrome.
Sherali AR, Moorani KN, Chishty SH, Khan SI.
J Coll Physicians Surg Pak; 2014 Feb 01; 24(2):110-3. PubMed ID: 24491005
[Abstract] [Full Text] [Related]
20. [Long-term outcome of children treated with the ISKDC regimen for the first episode of INS].
Hirano D, Nishizaki N, Kanai H, Hara S, Ohtomo Y, Umino D, Fujinaga S.
Nihon Jinzo Gakkai Shi; 2010 Feb 01; 52(8):1029-36. PubMed ID: 21254699
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
